Therapeutic effect of Ilex hainanensis Merr. Extract on essential hypertension: A systematic review and meta-analysis of randomized controlled trials

Frontiers in Pharmacology

Volumn 9, Issue MAY, 2018, Pages

  Yang, Xiaochen ^a   Yang, Guoyan ^b   Li, Weina ^a   Zhang, Yun ^a   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Hypertension; Ilex hainanensis Merr.; Meta analysis; Systematic review; Traditional Chinese medicine

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; FELODIPINE; ILEX HAINANENSIS EXTRACT; NITRENDIPINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE MASS; HUMAN; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 85046628552     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.00424     Document Type: Review

References (44)

1. Adriane, F. B. (2000). Herb-drug interactions. Lancet 355, 134-138. doi: 10.1016/S0140-6736(99)06457-0
2. Chen, X.-Q., Yang, J., Liu, X.-X., Laib, M.-X., and Wang, Q. (2009). Complete assignments of 1Hand 13CNMR spectral data for three new triterpenoid saponins from Ilex hainanensis Merr. Magn. Reson. Chem. 47, 169-173. doi: 10.1002/mrc.2355
3. Chena, X.-Q., Zana, K., Yanga, J., Laib, M.-X., and Wanga, Q. (2009). A novel flavanone from Ilex hainanensis Merr. Nat. Prod. Res. 23, 442-447. doi: 10.1080/14786410802044885
4. Carretero, O. A., and Oparil, S. (2000). Essential hypertension. Part I: definition and etiology. Circulation 101, 329-335. doi: 10.1161/01.CIR.101.3.329
5. Cui, W. X., Yang, J., Chen, X. Q., Mao, Q., Wei, X. L., Wen, X. D., et al. (2013). Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. Am. J. Chin. Med. 41, 487-502. doi: 10.1142/S0192415X13500353
6. Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., et al. (1986). Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57, 450-458. doi: 10.1016/0002-9149(86)90771-X
7. Ernst, E. (2000). Prevalence of use of complementary/alternative medicine: a systematic review. Bull. World Health Organ. 78, 252-257
8. Ford, E. S. (2011). Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 123, 1737-1744. doi: 10.1161/CIRCULATIONAHA.110.005645
9. Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924-926. doi: 10.1136/bmj.39489.470347.AD
10. Hang, C. L., and Cao, Q. R. (1984). Tea-based Traditional Chinese medicine resource-Shanlvcha. J. Chin. Med. Mat. 3, 18-36
11. Hao, P. P., Jiang, F., Cheng, Y. G., Yang, J., Zhang, K., Zhang, M. X., et al. (2015). Traditional Chinese medication for cardiovascular disease. Nat. Rev. Cardiol. 12, 115-122. doi: 10.1038/nrcardio.2014.177
12. Hao, P. P., Jiang, F., Cheng, J., Ma, L. Y., Zhang, Y., and Zhao, Y. X. (2017). Traditional Chinese medicine for cardiovascular disease. J. Am. Coll. Cardiol. 69, 2952-2966. doi: 10.1016/j.jacc.2017.04.041
13. Higgins, J. P. T., and Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration
14. Hui, Y. C., and Shu, Z. Q. (2002). The comparison of curative effect of Shanlvcha antihypertensive tablet in hypertensive patients with left ventricular hypertrophy compared with captopril. Chin. J. Integr.Tradit. West. Med. 22, 206-207. doi: 10.3321/j.issn:1003-5370.2002.03.034
15. Kario, K. (2013). Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation. Hypertens. Res. 36:564. doi: 10.1038/hr.2013.40
16. Li, P., Xie, J. X., Chen, Y., and Li, C. Y. (2008). Experimental study on the antihypertensive effect of different processed products of Shanlvcha. J. Chin. Med. Mater. 31, 1309-1312. doi: 10.3321/j.issn:1001-4454.2008.09.005
17. Liu, Y., Wei, H. Y., Long, J. C., and Jiang, Z. W. (2010). Pharmacodynamics of Shanlucha Antihypertensive Tablets for the Treatment of Hypertension with Vertigo and Headache. China J. Exp.Tradit. Med. Form. 16, 86-88. doi: 10.3969/j.issn.1005-9903.2010.01.029
18. Liu, J. (2002). Clinical effect of Shanlvcha antihypertensive tablet on 101 patients with essential hypertension. Hui Zhong Yi Lin Chuang Za Zhi 14, 339-340. doi: 10.3969/j.issn.1672-7134.2002.05.003
19. Markham, B., and Ternai, K. R. (1976). 13C NMR of flavonoids-II: flavonoids other then flavone and flavonol aglycones. Tetrahedron 32, 2607-2612. doi: 10.1016/0040-4020(76)88036-2
20. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D. G. (2009). The PRISMA group. preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 89:e1000097. doi: 10.1371/journal.pmed.1000097
21. Nagano, M., Higaki, J., Mikami, H., Nakamaru, M., Higashimori, K., Katahira, K., et al. (1991). Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J. Hypertens. 9, 595-599. doi: 10.1097/00004872-199107000-00003
22. NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389, 37-55. doi: 10.1016/S0140-6736(16)31919-5
23. Robinson, N. (2011). Integrative medicine-traditional Chinese medicine, a model? Chin. J. Integr. Med. 17, 21-25. doi: 10.1007/s11655-011-0602-9
24. Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., and Perticone, F. (2000). Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35, 580-586. doi: 10.1161/01.HYP.35.2.580
25. Schulz, K. F., Altman, D. G., and Moher, D. (2010). CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ 340:c332. doi: 10.1136/bmj.c332
26. Sheng, C. S., Liu, M. Y. Y., Kang, F., Wei, F., Zhang, L., Liu, Y., et al. (2013). Prevalence, awareness, treatment and control of hypertension in elderly Chinese. Hypertens. Res. 36, 824-828. doi: 10.1038/hr.2013.57
27. Su, F. Q., and Guo, L. F. (2015). Clinical effect of Shanlvcha capsule patients with elderly essential hypertension. Xian Dai Zhong Xi Yi Jie He Za Zhi 24, 1191-1192. doi: 10.3969/j.issn.1008-8849.2015.11.018
28. Sun, W. D., Liu, C., Zhang, Y. Q., Qiu, X., Zhang, L., Zhao, H. X., et al. (2017). Ilexgenin A, a novel pentacyclic triterpenoid extracted from Aquifoliaceae shows reduction of LPS-induced peritonitis in mice. Eur. J. Pharmacol. 797, 94-105. doi: 10.1016/j.ejphar.2017.01.019
29. Tachjian, A., Maria, V., and Arshad, J. (2010). Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol. 55, 515-525. doi: 10.1016/j.jacc.2009.07.074
30. Tang, Y. P., Liu, Y., and Fang, X. M. (2004). Clinical effect of Shanlvcha on 80 patients with elderly essential hypertension. Zhong Yi Yao Xue Kan 22, 1502-1503. doi: 10.3969/j.issn.1673-7717.2004.08.068
31. Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Gattobigio, R., Zampi, I., et al. (1998). Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97, 48-54. doi: 10.1161/01.CIR.97.1.48
32. Wang, J., Xiong, X. J., Yang, G. Y., Zhang, Y. Q., Liu, Y. M., Zhang, Y., et al. (2013). Chinese herbal medicine Qi Ju Di Huang Wan for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid. Based Complement Alternat. Med. 2013:262685. doi: 10.1155/2013/262685
33. Wang, J., Xiong, X. J., and Yang, X. C. (2014). Is it a new approach for treating senile hypertension with kidney-tonifying Chinese herbal formula? a systematic review of randomized controlled trials. Evid. Based Complement Alternat. Med. 2014:473038. doi: 10.1155/2014/473038
34. Windrum, P., Hull, D. R., and Morris, T. C. M. (2000). Herb-drug interactions, Lancet 355, 1019-1020. doi: 10.1016/S0140-6736(05)74767-X
35. Xiong, X., Yang, X., Duan, L., Liu, W., Zhang, Y., Liu, Y., et al. (2017). Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats. Sci. Rep. 7:42965. doi: 10.1038/srep42965
36. Xu, H., and Chen, K. J. (2008). Integrative medicine: the experience from China. J. Alternat. Complement. Med. 14, 3-7. doi: 10.1089/acm.2006.6329
37. Yang, Y. T., Wu, J. Q., Yu, S. W., and Shen, Y. M. (2000). Clinical observation on hypertension treated by shanlvcha tablets for decreasing blood pressure. Chin. J. Inf. Tradit. Chin. Med. 7, 36-37. doi: 10.3969/j.issn.1005-5304.2000.07.018
38. Yang, X., Sun, K., Zhang, W., Wu, H., Zhang, H., and Hui, R. (2007). Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese. J. Vasc. Surg. 46, 296-302. doi: 10.1016/j.jvs.2007.03.034
39. Yang, J., Lv, F., Chen, X. Q., Cui, W. X., Chen, L. H., Wen, X. D., et al. (2013). Pharmacokinetic study of major bioactive components in rats after oral administration of extract of Ilex hainanensis by high-performance liquid chromatography/electrospray ionization mass spectrometry. J. Pharm. Biomed. Anal. 77, 21-28. doi: 10.1016/j.jpba.2013.01.011
40. Yang, X., Zhao, H., and Wang, J. (2014). Chinese massage (Tuina) for the treatment of essential hypertension: a systematic review and meta-analysis. Complement Ther. Med. 22, 541-548. doi: 10.1016/j.ctim.2014.03.008
41. Yang, X. C., Xiong, X. J., Yang, G. Y., Wang, H. R., and Wang, J. (2015). Songling Xuemaikang Capsule for primary hypertension: a systematic review of randomized controlled trials. Chin. J. Integr. Med. 21, 312-320. doi: 10.1007/s11655-014-1709-6
42. Yang, J. (2006). The different dose of Shanlvcha antihypertensive tablet in hypertensive patients with left ventricular hypertrophy. Guang Xi Yi Xue 28, 1375-1376. doi: 10.3969/j.issn.0253-4304.2006.09.028
43. Yin, R. Z., Wang, J. Q., Wang, S., Bao, Y. R., and Meng, X. S. (2015). The research progress of Ilex hainanensis Merr. in clinical practice. J. Liaoning Univ. TCM 17, 81-84. doi: 10.13194/j.issn.1673-842x.2015.12.026
44. Zhou, X.-S., Yang, S.-J., Liu, C.-F., and Tu, F.-P. (2007). Triterpenoids from the leaves of Ilex hainanensis. Helvetica Chimica Acta 90, 121-127. doi: 10.1002/hlca.200790005